| Description | Fezakinumab is a potent monoclonal antibody to interleukin-22 (IL-22). Fezakinumab can be used to study immune system diseases and inflammation-related conditions such as psoriasis, rheumatoid arthritis and atopic dermatitis. |
| Synonyms | ILV 094 |
| molecular weight | N/A |
| CAS | 1007106-86-6 |
| Storage | store at low temperature | store at -80°C |
| References | 1. Patrick M Brunner, et al. Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab. J Allergy Clin Immunol |